|
|
Title | Creator | Description | Identifier |
1 |
|
Therapies for Multiple Sclerosis | Sashank Prasad, MD, Brigham and Women's Hospital | Recent progress makes it clear that we are in a new era regarding therapeutics for multiple sclerosis (MS). After a long history of treating MS symptomatically, the past two decades have brought a new armamentarium of diseasemodifying therapies that modulate the autoimmune response in a variety of w... | 20130211_nanos_journalclubsympos_03-1 |
2 |
|
Therapies for Multiple Sclerosis | Sashank Prasad, MD, Brigham and Women's Hospital | Recent progress makes it clear that we are in a new era regarding therapeutics for multiple sclerosis (MS). After a long history of treating MS symptomatically, the past two decades have brought a new armamentarium of diseasemodifying therapies that modulate the autoimmune response in a variety of w... | 20130211_nanos_journalclubsympos_03-2 |
3 |
|
Therapies for Multiple Sclerosis | Sashank Prasad, MD, Brigham and Women's Hospital | Recent progress makes it clear that we are in a new era regarding therapeutics for multiple sclerosis (MS). After a long history of treating MS symptomatically, the past two decades have brought a new armamentarium of diseasemodifying therapies that modulate the autoimmune response in a variety of w... | 20130211_nanos_journalclubsympos_03 |